In sum, our data illustrated the strong association between EGFR genomic alterations and increased expression of ERK5 which could phosphorylate the PRPS1/2, activated nuclear biosynthesis pathway, and in turn might promote tumor cell proliferation and impact prognosis (Fig. 4T). The gene discussed is PRPS1; the disease is neoplasm.